Retired Assistant Commissioner of Police, Winston Cosbert, was last evening given the Terms of Reference (TORs) by Minister of State, Joseph Harmon, to probe into the allegations of unauthorised disclosure of information,
mismanagement and malpractices in the procurement of pharmaceuticals at the Ministry of Public Health.
In handing over the TORs, Minister Harmon said that Government eagerly awaits that report and the findings, so that appropriate action can be taken, a Ministry of the Presidency release said.
“I have the confidence in your ability; I have seen your work before and you have done inquiries before. I look forward to the report. This is an important inquiry … and when you have to go after these things, you have to have evidence and facts [because] Government cannot act on innuendos and hearsay. We have to have an investigation and based on that, the Government acts,” the Minister said.
The Board of Inquiry (BoI) will commence today and is expected to render its written report and findings to the Minister of State on or before November 30, 2016.
The inquiry is expected to take place at the Department of Public Service and at any other place, in which the Commissioner deems fit.
The board is expected to investigate, examine and report on the “procurement and management processes by which the Ministry of Public Health awards contracts for the procurement of pharmaceuticals, services and supplies to bidders; whether there was unauthorised disclosure of any information on the procurement of pharmaceuticals by the staff of the Ministry of Public Health and the facts surrounding such unauthorised disclosure; the facts surrounding the allegation that Ms. Kandasie Aaron, without prior consent from the Ministry of Public Health, divulged any information on the procurement of pharmaceuticals; to what extent this specific disclosure is an isolated incident and if not, does it represent a more general practice at the Ministry of Public Health.”
It is also expected to investigate the procedure which exists to identify and control the unauthorised disclosure of price sensitive information in the procurement of pharmaceuticals and how and when did the Ministry of Public Health become aware of these disclosures and what actions, if any, were taken by the Ministry.
According to the Ministry, after the investigation and findings, recommendations must be made for measures that could strengthen information management systems within the Ministry to improve the handling of protected information and deter any unauthorised disclosures; and remedial actions, or any other actions, against staff who are found to have acted improperly in the discharge of their public duties and those persons who have benefited from the actions of the public officials and for criminal prosecution or other actions, if any, against any such person found to have engaged in criminal or improper conduct.
Last month, it was disclosed that a major probe would be launched at the Ministry after disclosures that confidential procurement information, which could give a bidder an edge in the tendering process, was leaked.
Over the years, under the previous administration of the People’s Progressive Party/Civic (PPP/C), there were widespread allegations of wrongdoing with the procurement of pharmaceuticals to the tune of billions of dollars annually.
Apr 02, 2020The National Sports Commission (NSC) has informed the media via a Press Release that the general public is advised that all facilities under the commission will remain closed until May 01, 2020. List...
Apr 02, 2020
Apr 02, 2020
Apr 02, 2020
Apr 02, 2020
Apr 01, 2020
History is replete with the destructive side of human nature. In countless instances, the mind is unable to grasp the motives... more
By Sir Ronald Sanders On 20 March 2020, a reckless and irresponsible General Assembly (GA) was held by the Organization... more
Editor’s Note, If your sent letter was not published and you felt its contents were valid and devoid of libel or personal attacks, please contact us by phone or email.
Feel free to send us your comments and/or criticisms.
Contact: 624-6456; 225-8452; 225-8458; 225-8463; 225-8465; 225-8473 or 225-8491.
Or by Email: [email protected] / [email protected]